Alzheimer's Drug Discovery Foundation Investor
The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease. Our pioneering biomedical venture philanthropy approach allows us to invest in the most promising drug discovery and development programs around the world in both academic institutions and biopharmaceutical companies. Since our founding in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.
Headquarters:
New York,New York,United States,North America
Industry:
AI in HealthTech
Investor Type:
Donors
Founded Date:
1998-01-01
Funding Status:
private